Literature DB >> 24864614

Non-Hodgkin's thyroid lymphoma associated with Hashimoto's thyroiditis.

Tamseela Ahmed, Naila Kayani, Zubair Ahmad, Muhammad Naeemul Haque.   

Abstract

We report two cases of thyroid lymphoma. First was of a 54-year-old lady who presented with a 10 year history of goiter. Examination revealed an enlarged thyroid gland extending sub-sternally, with no palpable lymph nodes. She had been on thyroxine for 4 months, due to a high TSH with positive antibodies. Fine needle aspiration cytology of thyroid showed Hashimoto thyroiditis (HT). A total thyroidectomy was done because of pressure symptoms. Histopathology revealed HT in right lobe and Diffuse Large B-cell Non-Hodgkin's lymphoma (DLBCL) in left lobe. Second case was of a 30 year-old man who presented with dyspnoea secondary to rapidly enlarging thyroid. On examination, thyroid was diffusely enlarged together with palpable lymph nodes. His TSH was elevated & Anti-TPO antibodies were positive suggesting an autoimmune etiology. Ultrasound showed, an ill-defined heterogeneous mass in the left lobe of thyroid gland with multiple enlarged lymph nodes. Ultrasound guided thyroid core biopsy revealed DLBCL.

Entities:  

Mesh:

Year:  2014        PMID: 24864614

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  3 in total

1.  Thyroiditis: a Clinico-cytomorphological Study with a Reference to the Ethnic Groups of Northeast Regions of India.

Authors:  Abhijit Kalita; Ronica Baruah
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2015-09-15

2.  Tracheoesophageal fistula caused by chemotherapy in primary thyroid lymphoma: a case report.

Authors:  Chun Wang; Zhirong Li; Wuguo Tian
Journal:  Transl Cancer Res       Date:  2021-07       Impact factor: 1.241

3.  Comparison of the clinical characteristics of primary thyroid lymphoma and diffuse sclerosing variant of papillary thyroid carcinoma.

Authors:  Xiaoya Zheng; Shanshan Yu; Jian Long; Qiang Wei; Liping Liu; Chun Liu; Wei Ren
Journal:  Endocr Connect       Date:  2022-01-27       Impact factor: 3.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.